Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aefe33a95ef6b6532182cf4c602c8ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a45ec6088a0d9febda4d31c577e15607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ead844acecf2869b5ff00b20a7eecc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f861d7dfdde7b233339d4838364a8e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3189a37bd5eebd67834698d63a1e36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b24c62ea72a5d34a9f5b26162580875 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-14 |
filingDate |
2009-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235e0f373d2b0c800e6098c6b3f12535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ba8fe8ef5378c2171046a4446d822d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f76eb6df30d2977509a53ce3be79a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ab3f18f5fb5ca8ffe582c347e91159 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2334196ca16ea772ebeffef62dccb4e |
publicationDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9974825-B2 |
titleOfInvention |
Peptides Des-[Asp1]-[Ala1], angiotensin-(1-7) agonist and pharmaceutical compositions for the treatment of diseases |
abstract |
The present invention is related to the peptide Des-[Asp 1 ]-[Ala 1 ]-Angiotensin-(1-7) (Ala 1 -Arg 2 -Val 3 -Tyr 4 -Ile 5 -His 6 -Pro 7 ) (SEQ ID NO: 1) and/or its related compounds as vasodilating and cardioprotective agents to be used in mammals. This invention also comprises the production of compounds containing Des-[Asp 1 ]-[Ala 1 ]-Angiotensin-(1-7) and/or its related compounds and its use in methods for treating and preventing diseases. |
priorityDate |
2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |